Pancreatic Acinar Cell Carcinoma

9 clinical trials · Condition

Record	Firm	Date
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation (NCT04858334)	National Cancer Institute (NCI)	2021-06-22
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042)	General Oncology, Inc.	2021-01-13
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)	National Cancer Institute (NCI)	2017-01-30
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy (NCT01658943)	National Cancer Institute (NCI)	2012-08-01
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer (NCT01280058)	National Cancer Institute (NCI)	2010-12-01
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery (NCT00669734)	National Cancer Institute (NCI)	2010-02-01
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery (NCT00878163)	National Cancer Institute (NCI)	2009-03-31

Every clearance here is in the API, with alerts when new ones post.